Infographic: The port delivery system with ranibizumab for neovascular age-related macular degeneration: LADDER trial

IF 2.8 3区医学 Q1 OPHTHALMOLOGY

Eye Pub Date : 2024-09-18 DOI:10.1038/s41433-024-03337-1

Ishani Barai, Sobha Sivaprasad, Christin Henein

引用次数: 0

Abstract

Reference to original article:

Campochiaro, P. A., Marcus, D. M., Awh, C.C. et al. The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 ladder clinical trial. Ophthalmology, 126(8), 1141–1154.

Abstract Image

查看原文本刊更多论文

信息图：使用雷尼珠单抗治疗新生血管性老年黄斑变性的端口给药系统：LADDER试验

原文参考文献：Campochiaro, P. A., Marcus, D. M., Awh, C.C. et al.使用雷尼珠单抗治疗新生血管性年龄相关性黄斑变性的端口给药系统：随机2期阶梯临床试验结果。眼科学》，126（8），1141-1154。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Eye 医学-眼科学

CiteScore

6.40

自引率

5.10%

发文量

481

审稿时长

3-6 weeks

期刊介绍： Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists. Eye encourages the submission of original articles covering all aspects of ophthalmology including: external eye disease; oculo-plastic surgery; orbital and lacrimal disease; ocular surface and corneal disorders; paediatric ophthalmology and strabismus; glaucoma; medical and surgical retina; neuro-ophthalmology; cataract and refractive surgery; ocular oncology; ophthalmic pathology; ophthalmic genetics.